Atlas Trials

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers

Clinical trial NCT07351591 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07351591
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract Cancer(BTC)
Start date
2026-01-30
Primary completion
2026-10-30
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.